Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non‐obstructive urinary retention: >10 years of clinical experience

E. Chartier-Kastler

DOI: https://doi.org/10.1111/j.1464-410X.2007.07233.x

2007-12-07

BJU International

Abstract:Overactive bladder (OAB) syndrome is a common condition affecting millions of people in the Western world. It is typically associated with urgency, with or without urge urinary incontinence (UUI), usually with frequency and nocturia [1]. The International Consultation on Incontinence (ICI), and other international guidelines, currently recommend diet and lifestyle modifications and behavioural therapy (e.g. pelvic floor muscle training, bladder retraining or biofeedback) in combination with antimuscarinic therapy as first-line treatment for patients with OAB [2]. However, in many patients conservative therapy does not sufficiently alleviate the symptoms of OAB. A study conducted in 2002 in 21 362 patients showed that at 1 year after the first prescription, only 15% of patients remained on OAB medication (Fig. 1) [3]. In most cases, patients stop taking medication because of lack of efficacy or side-effects. A survey among 1447 people receiving treatment for UI showed that younger patients ( < 50 years old) are twice as likely to stop using antimuscarinic agents as are older patients [4]. Up to a few years ago the only alternative therapies for these patients were invasive and irreversible surgical procedures, e.g. augmentation cystoplasty and urinary diversion. These procedures are associated with significant shortand long-term risk and morbidity, and in many cases the treatment becomes more bothersome than the condition itself. Therefore, surgery (as bladder enlargement) should be considered as a last resort when all other treatment options have failed.